Toggle Health Problems and D

Vitamin D trial for COVID-19 – using their patented slow-release form – Aug 2021

OPKO patented a slow release form of Vitamin D to treat Chronic Kidney Disease in 2014
It is extremely expensive, and now the company hopes to show that it fight COVID-19
Standard, far lower cost, over-the-counter vitamin D would be better, but Vitamin D would not profit the company
Note: The trial is comparing the product against a placebo, not against vitamin D
__OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients Yahoo Finance Aug 30. 2021




COVID-19 treated by Vitamin D - studies, reports, videos

5 most-recently changed Virus entries

Intervention and virus studies:

Created by admin. Last Modification: Monday September 6, 2021 01:32:50 GMT-0000 by admin. (Version 7)